These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25189204)

  • 1. Is prophylactic psychiatry around the corner? combating adolescent oxidative stress for adult psychosis and schizophrenia.
    Sawa A; Seidman LJ
    Neuron; 2014 Sep; 83(5):991-3. PubMed ID: 25189204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia.
    Cabungcal JH; Counotte DS; Lewis E; Tejeda HA; Piantadosi P; Pollock C; Calhoon GG; Sullivan E; Presgraves E; Kil J; Hong LE; Cuenod M; Do KQ; O'Donnell P
    Neuron; 2014 Sep; 83(5):1073-1084. PubMed ID: 25132466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.
    Conus P; Seidman LJ; Fournier M; Xin L; Cleusix M; Baumann PS; Ferrari C; Cousins A; Alameda L; Gholam-Rezaee M; Golay P; Jenni R; Woo TW; Keshavan MS; Eap CB; Wojcik J; Cuenod M; Buclin T; Gruetter R; Do KQ
    Schizophr Bull; 2018 Feb; 44(2):317-327. PubMed ID: 29462456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using prophylactic antioxidants to prevent noise-induced hearing damage in young adults: a protocol for a double-blind, randomized controlled trial.
    Gilles A; Ihtijarevic B; Wouters K; Van de Heyning P
    Trials; 2014 Apr; 15():110. PubMed ID: 24708640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia.
    Romero-Miguel D; Casquero-Veiga M; Lamanna-Rama N; Torres-Sánchez S; MacDowell KS; García-Partida JA; Santa-Marta C; Berrocoso E; Leza JC; Desco M; Soto-Montenegro ML
    Transl Psychiatry; 2024 Jan; 14(1):14. PubMed ID: 38191622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of N-acetylcysteine in the treatment of schizophrenia].
    Miyake N; Miyamoto S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2016 Apr; 36(2):29-35. PubMed ID: 27333656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation.
    Lanté F; Meunier J; Guiramand J; De Jesus Ferreira MC; Cambonie G; Aimar R; Cohen-Solal C; Maurice T; Vignes M; Barbanel G
    Hippocampus; 2008; 18(6):602-9. PubMed ID: 18306297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic N-Acetylcysteine Treatment Prevents Amphetamine-Induced Hyperactivity in Heterozygous
    Lai CC; Baskaran R; Tsao CY; Tuan LH; Siow PF; Palani M; Lee LJ; Liu CM; Hwu HG; Lee LJ
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylcysteine as a potentially useful medication to prevent conversion to schizophrenia in at-risk individuals.
    Asevedo E; Cunha GR; Zugman A; Mansur RB; Brietzke E
    Rev Neurosci; 2012; 23(4):353-62. PubMed ID: 22944654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal Risks and Childhood Premorbid Indicators of Later Psychosis: Next Steps for Early Psychosocial Interventions.
    Liu CH; Keshavan MS; Tronick E; Seidman LJ
    Schizophr Bull; 2015 Jul; 41(4):801-16. PubMed ID: 25904724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia.
    Roes EM; Raijmakers MT; Boo TM; Zusterzeel PL; Merkus HM; Peters WH; Steegers EA
    Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):61-7. PubMed ID: 16243427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant administration to the mother prevents oxidative stress associated with birth in the neonatal rat.
    Sastre J; Asensi M; Rodrigo F; Pallardó FV; Vento M; Viña J
    Life Sci; 1994; 54(26):2055-9. PubMed ID: 8208062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential protection of pre- versus post-treatment with curcumin, Trolox, and N-acetylcysteine against acrylonitrile-induced cytotoxicity in primary rat astrocytes.
    Yu B; Changsheng Y; Wenjun Z; Ben L; Hai Q; Jing M; Guangwei X; Shuhua W; Fang L; Aschner M; Rongzhu L
    Neurotoxicology; 2015 Dec; 51():58-66. PubMed ID: 26409646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated intermittent administration of (R)-ketamine during juvenile and adolescent stages prevents schizophrenia-relevant phenotypes in adult offspring after maternal immune activation: a role of TrkB signaling.
    Tan Y; Fujita Y; Pu Y; Chang L; Qu Y; Wang X; Hashimoto K
    Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):693-701. PubMed ID: 34977960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenia as a disorder of neurodevelopment.
    Lewis DA; Levitt P
    Annu Rev Neurosci; 2002; 25():409-32. PubMed ID: 12052915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 fatty acids during adolescence prevent schizophrenia-related behavioural deficits: Neurophysiological evidences from the prenatal viral infection with PolyI:C.
    Casquero-Veiga M; Romero-Miguel D; MacDowell KS; Torres-Sanchez S; Garcia-Partida JA; Lamanna-Rama N; Gómez-Rangel V; Romero-Miranda A; Berrocoso E; Leza JC; Arango C; Desco M; Soto-Montenegro ML
    Eur Neuropsychopharmacol; 2021 May; 46():14-27. PubMed ID: 33735708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of cognitive function in schizophrenia with
    Yolland COB; Phillipou A; Castle DJ; Neill E; Hughes ME; Galletly C; Smith ZM; Francis PS; Dean OM; Sarris J; Siskind D; Harris AWF; Rossell SL
    Nutr Neurosci; 2020 Feb; 23(2):139-148. PubMed ID: 29847303
    [No Abstract]   [Full Text] [Related]  

  • 18. Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection.
    Lieberman JA; Malaspina D; Jarskog LF
    CNS Spectr; 2006 Apr; 11(4):suppl 1-13; quiz suppl 14-5. PubMed ID: 16641837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection -- a pilot study.
    Skov M; Pressler T; Lykkesfeldt J; Poulsen HE; Jensen PØ; Johansen HK; Qvist T; Kræmer D; Høiby N; Ciofu O
    J Cyst Fibros; 2015 Mar; 14(2):211-8. PubMed ID: 25458464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous glutathione prevents renal oxidative stress after coronary angiography more effectively than oral N-acetylcysteine.
    Saitoh T; Satoh H; Nobuhara M; Machii M; Tanaka T; Ohtani H; Saotome M; Urushida T; Katoh H; Hayashi H
    Heart Vessels; 2011 Sep; 26(5):465-72. PubMed ID: 21127883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.